Telomir Announces Research with The Ohio State University Demonstrating In-Vitro Anti-Cancer Activity in Human and Canine Osteosarcoma Models
Telomir Pharmaceuticals announced new research from The Ohio State University demonstrating that their compound Telomir-Zn inhibits cell growth effectively in human and canine osteosarcoma cell lines, suggesting potential for both veterinary and human therapeutic development. The company is advancing its triple-negative breast cancer (TNBC) program…